Skip to main content
MedPathMedPath Home
Clinical Trials/NL-OMON23413
NL-OMON23413
Recruiting
Not Applicable

Identification of muscle-invasive bladder cancer patients who will not benefit from neoadjuvant chemotherapy using circulating tumor cells.

Erasmus MC0 sites260 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
Erasmus MC
Enrollment
260
Status
Recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

/A

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational non invasive

Investigators

Sponsor
Erasmus MC

Eligibility Criteria

Inclusion Criteria

  • •Histopathologically confirmed muscle\-invasive urothelial carcinoma of the bladder.
  • •\- Clinical stage T2\-T4a N0\-N1 bladder cancer.

Exclusion Criteria

  • •\- Muscle\-invasive bladder cancer other than urothelial carcinoma (adenocarcinoma, squamous cell carcinoma, small cell carcinoma, neuro\-endocrine tumor).
  • •\- History of other malignant disease with a tumor\-free interval of less than 5 years.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Identification of muscle-invasive bladder cancer patients who will not benefit from neoadjuvant chemotherapy using circulating tumor cells.muscle invasive bladder cancermuscle invasive bladder carcinoma1003836410004994
NL-OMON45144Erasmus MC, Universitair Medisch Centrum Rotterdam320
Active, not recruiting
Not Applicable
Detection of bladder cancer using a fluorescent dye (PVP-Hypericin)Suspected non-muscle invasive (superficial) bladder cancerMedDRA version: 17.0Level: PTClassification code 10005003Term: Bladder cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Diagnosis [E01]
EUCTR2011-001819-30-DESanochemia Pharmazeutika AG220
Active, not recruiting
Not Applicable
Detection of bladder cancer using a fluorescent dye (PVP-Hypericin)Suspected non-muscle invasive (superficial) bladder cancerMedDRA version: 17.0Level: PTClassification code 10005003Term: Bladder cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Diagnosis [E01]
EUCTR2011-001819-30-ATSanochemia Pharmazeutika AG220
Completed
Phase 2
Detection of non-muscle invasive bladder cancer using PVP-Hypericin (Vidon®) fluorescence cystoscopy(Hypericin PDD)C67Malignant neoplasm of bladder
DRKS00003324Sanochemia Pharmazeutika AG227
Recruiting
Not Applicable
Multi-parametric MRI in Patients of Bladder CancerMuscle-invasive Bladder CancerArtificial Intelligence
NCT06362330The First Affiliated Hospital with Nanjing Medical University1,000